Bushido Capital US SMID Cap Equity ETF Rating $32.32 0.00 (0.00%) As of 06/12/2026 11:57 AM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsRatingsShort InterestTrendsBuy This Stock Bushido Capital US SMID Cap Equity ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.RNIN Aggregate RatingHold 2.49Holdings in RNIN have an aggregate rating of Hold based on 335 analyst ratings issued in the past year covering 25 companies (39.2% of the portfolio).RNIN Aggregate Price Target$32.32High Prediction$32.32Average Prediction$32.32Low Prediction$32.32Holdings in RNIN have an aggregate price target of $32.32 and a range of $32.32 to $32.32 covering 25 companies (39.2% of the portfolio).RNIN Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy14 Moderate Buy rating(s)Hold10 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Bushido Capital US SMID Cap Equity ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 RNIN Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings2.19%OSCROscar Health$28.29+0.1%3.3912 of 5 stars2.17$20.78 -26.6%12Analyst Upgrade1.90%SNXTD SYNNEX$280.91+0.1%4.1278 of 5 stars2.82$233.10 -17.0%11Positive News1.77%TENBTenable$26.802.8628 of 5 stars2.40$29.16 8.8%201.72%MNKDMannKind$3.662.9421 of 5 stars2.60$8.97 145.0%10Gap Up1.71%CROXCrocs$124.711.987 of 5 stars2.50$117.64 -5.7%20Gap Up1.71%PTONPeloton Interactive$5.554.4488 of 5 stars2.29$8.25 48.6%14Positive News1.64%PDPagerDuty$8.96-0.1%3.802 of 5 stars2.09$11.25 25.6%11Gap Down1.63%ONonsemi$116.793.5751 of 5 stars2.50$92.96 -20.4%30Trending News1.59%PGNYProgyny$26.634.1753 of 5 stars2.79$29.67 11.4%14Positive NewsGap Down1.57%NTNXNutanix$49.313.9191 of 5 stars2.56$60.00 21.7%18Analyst Downgrade1.56%VCVisteon$118.443.6791 of 5 stars2.64$125.67 6.1%141.56%BWABorgWarner$74.61+0.1%2.9264 of 5 stars2.60$74.00 -0.8%15Positive News1.55%ETSYEtsy$69.470.0%2.3127 of 5 stars2.34$71.00 2.2%32Analyst Forecast1.51%NUTXNutex Health$144.403.7077 of 5 stars2.67$220.00 52.4%31.50%TGTXTG Therapeutics$49.522.3093 of 5 stars2.71$52.50 6.0%7Gap Down1.48%NTCTNetScout Systems$41.422.3455 of 5 stars3.00$35.50 -14.3%41.47%JAZZJazz Pharmaceuticals$230.563.3405 of 5 stars2.84$246.06 6.7%19Trending NewsInsider Trade1.47%CPRXCatalyst Pharmaceuticals$31.363.6737 of 5 stars2.56$32.00 2.0%91.45%CRMDCorMedix$8.743.4333 of 5 stars2.75$15.00 71.6%8Gap Up1.42%NEUNewMarket$832.67-0.1%0.9861 of 5 stars2.0011.38%TRIPTripAdvisor$12.413.2645 of 5 stars2.00$14.76 19.0%16Options VolumeGap Down1.36%HRMYHarmony Biosciences$34.464.4861 of 5 stars2.27$40.89 18.7%11Gap Up1.35%QLYSQualys$111.243.5982 of 5 stars2.06$122.14 9.8%17Positive News1.35%HRBH&R Block$36.41-0.3%4.4474 of 5 stars2.50$41.00 12.6%41.34%FRSHFreshworks$9.44-0.1%4.0037 of 5 stars2.47$12.18 29.0%15 This page (NASDAQ:RNIN) was last updated on 6/15/2026 by MarketBeat.com Staff. From Our PartnersLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredIs SpaceX really worth 1.78 Trillion?With SpaceX approaching a near-$2 trillion valuation, most investors are focused on the IPO itself - but analy...InvestPub | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredSpaceX is chump change compared to Elon’s $20T ‘iPhone’Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...StocksToTrade | SponsoredThe roadshow starts Monday. This stock isn't ready.The SpaceX roadshow kicks off June 8. Goldman Sachs, the lead underwriter, will present the full S-1 to the wo...Behind the Markets | SponsoredTrump just signed itA recent policy development is drawing attention from income-focused investors. According to one analyst, c...Investors Alley | SponsoredThis is the worst news for stocks in 50 yearsGoldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...TradeSmith | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bushido Capital US SMID Cap Equity ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Bushido Capital US SMID Cap Equity ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
